Helpful Discussion Topics About Potential Treatment Benefits1

Patients reported that improving QOL and symptoms and disease control were most helpful when discussing treatment benefits

Reference

  1. Biru Y, Clavreul S, Rasche L, et al. Differences in treatment goals and expectations among patients with relapsed/refractory multiple myeloma treated in academic vs community settings. Presented at: 22nd IMS Annual Meeting; September 17-20, 2025; Toronto, Canada. Poster PA-484. © 2025 International Myeloma Society. Reused with permission. This poster was accepted and previously presented at the 2025 IMS Annual Meeting. All rights reserved.